Faruqi and Faruqui, LLP Logo
Share this page

Trevena, Inc. (TRVN)

NASDAQ:TRVN

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Trevena, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ:TRVN) of the December 10, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Trevena stock or options between May 2, 2016 and October 8, 2018 and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

The lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of all those who purchased Trevena common stock between May 2, 2016 and October 8, 2018 (the “Class Period”).  The case, Tomaszewski v. Trevena, Inc. et al., No. 18-cv-04378 was filed on October 10, 2018 and has been assigned to Judge Cynthia M. Rufe.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by misleading shareholders to believe that its End-of-Phase 2 Meeting with the Food and Drug Administration (“FDA”) for its flagship drug, oliceridine, was more successful than it actually was.

Specifically, on October 9, 2018, the FDA released its Briefing Document ahead of its scheduled meeting with Trevena to determine whether oliceridine would be granted approval for commercial use. The Briefing Document revealed that the FDA did not agree with the Company over its proposed dosing in the Phase 3 studies, the proposed primary endpoint, and proposed non-inferiority margin for comparing morphine to oliceridine.

On this news, the Company’s stock price fell from $2.98 per share on October 8, 2018 to $1.07 per share on October 9, 2018—a $1.91 or 64.1% drop.

Contact Us

To contact Faruqi & Faruqi, LLP please call (877) 247-4292 or (212) 983-9330, or please
fill out the form below and a Firm representative will contact you.

  • Case:
    Trevena, Inc. (TRVN)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 10/12/2018

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.